Cardiff Oncology (CRDF) Research & Development (2016 - 2025)
Historic Research & Development for Cardiff Oncology (CRDF) over the last 15 years, with Q3 2025 value amounting to $8.2 million.
- Cardiff Oncology's Research & Development fell 1496.89% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 1450.26%. This contributed to the annual value of $36.9 million for FY2024, which is 1215.87% up from last year.
- Per Cardiff Oncology's latest filing, its Research & Development stood at $8.2 million for Q3 2025, which was down 1496.89% from $11.6 million recorded in Q2 2025.
- Over the past 5 years, Cardiff Oncology's Research & Development peaked at $11.6 million during Q2 2025, and registered a low of $3.3 million during Q1 2021.
- Its 5-year average for Research & Development is $7.6 million, with a median of $8.0 million in 2024.
- Per our database at Business Quant, Cardiff Oncology's Research & Development surged by 11982.31% in 2022 and then crashed by 1496.89% in 2025.
- Over the past 5 years, Cardiff Oncology's Research & Development (Quarter) stood at $5.8 million in 2021, then increased by 10.61% to $6.4 million in 2022, then rose by 20.51% to $7.8 million in 2023, then rose by 25.11% to $9.7 million in 2024, then decreased by 15.6% to $8.2 million in 2025.
- Its Research & Development was $8.2 million in Q3 2025, compared to $11.6 million in Q2 2025 and $10.5 million in Q1 2025.